1. Genome‐wide analysis of the mouse LIM gene family reveals its roles in regulating pathological cardiac hypertrophy
- Author
-
Jieqiong Zhao, Mingming Zhang, Fangfang Wang, Jingxiao Yang, and Guangwei Zeng
- Subjects
Male ,animal structures ,LIM-Homeodomain Proteins ,Biophysics ,Cardiomegaly ,Genomics ,Biology ,Biochemistry ,Muscle hypertrophy ,Electrocardiography ,Structural Biology ,Genetics ,medicine ,Animals ,Gene family ,Molecular Biology ,Gene ,Pathological ,Cytoskeleton ,Phylogeny ,LIM domain ,Heart Failure ,Heart development ,Heart ,Cell Biology ,LIM Domain Proteins ,medicine.disease ,Rats ,Cell biology ,DNA-Binding Proteins ,Mice, Inbred C57BL ,Cytoskeletal Proteins ,Gene Expression Regulation ,Multigene Family ,Heart failure ,embryonic structures ,Carrier Proteins - Abstract
LIM-domain proteins have been shown to be associated with heart development and diseases. Systematic studies of LIM family members at the genome-wide level, which are crucial to further understand their functions in cardiac hypertrophy, are currently lacking. Here, 70 LIM genes were identified and characterised in mice. The expression patterns of LIM genes differ greatly during cardiac development and in the case of hypertrophy. Both Crip2 and Xirp2 are differentially expressed in cardiac hypertrophy and during heart failure. In addition, the hypertrophic state of cardiomyocytes is controlled by the relative expression levels of Crip2 and Xirp2. This study provides a foundation for further understanding of the special roles of LIM proteins in mammalian cardiac development and hypertrophy.
- Published
- 2021
- Full Text
- View/download PDF